Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04676334
What this trial is testing

CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib

Who this might be right for
Metastatic Castration-Resistant Prostate CancerOvarian CancerEpithelial Ovarian Cancer+3 more
pharmaand GmbH 34
Not applicableActive Not RecruitingNCT04141709
What this trial is testing

Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer

Who this might be right for
Oligometastatic DiseaseProstatic Cancer, Castration-Resistant
Technische Universität Dresden 66
Testing effectiveness (Phase 2)Ended earlyNCT01816048
What this trial is testing

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Who this might be right for
Prostatic NeoplasmsProstate Cancer
University of Wisconsin, Madison 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747
What this trial is testing

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
M.D. Anderson Cancer Center 173
Testing effectiveness (Phase 2)Study completedNCT00140348
What this trial is testing

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Who this might be right for
Prostate Cancer
Cell Genesys 80
Testing effectiveness (Phase 2)Ended earlyNCT01681433
What this trial is testing

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Who this might be right for
Prostate CancerMetastatic Castrate-Resistant Prostate CancerPSA
Costantine Albany 72
Early research (Phase 1)Looking for participantsNCT05488548
What this trial is testing

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Castrate Resistant Prostate CancerNUT CarcinomaChronic Myelomonocytic Leukemia+1 more
Epigenetix, Inc. 75
Testing effectiveness (Phase 2)Ended earlyNCT00996502
What this trial is testing

Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 4
Testing effectiveness (Phase 2)Study completedNCT00987753
What this trial is testing

Study Evaluating the Safety and Tolerability of L-377202

Who this might be right for
Hormone Refractory Prostate CancerProstate Cancer
University of Alabama at Birmingham 13
Early research (Phase 1)Study completedNCT00381173
What this trial is testing

ZYC300 Administered With Cyclophosphamide Pre-Dosing

Who this might be right for
Breast CancerOvarian CancerProstate Cancer+2 more
Eisai Inc. 22
Post-approval studies (Phase 4)Study completedNCT02441894
What this trial is testing

Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 21
Testing effectiveness (Phase 2)Study completedNCT02711956
What this trial is testing

ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 75
Not applicableUnknownNCT05188911
What this trial is testing

Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerMetastatic Disease
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT01695044
What this trial is testing

PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 119
Testing effectiveness (Phase 2)Study completedNCT02601014
What this trial is testing

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

Who this might be right for
Prostate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05011188
What this trial is testing

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerProstate Cancer
Rahul Aggarwal 44
Large-scale testing (Phase 3)Study completedNCT00116142
What this trial is testing

Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 350
Testing effectiveness (Phase 2)Study completedNCT00459654
What this trial is testing

A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer

Who this might be right for
Prostate CancerNeoplasm Metastasis
Bayer 64
Testing effectiveness (Phase 2)Ended earlyNCT02640534
What this trial is testing

Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone

Who this might be right for
Cancer of the ProstateProstate Cancer
Swiss Cancer Institute 169
Next Page